MRTX
Mirati Therapeutics Inc
$58.7
Earnings Summary
Revenue | $16.4Mn |
Net Profits | $-161.9Mn |
Net Profit Margins | -987.22% |
Highlights
Mirati Therapeutics Inc’s revenue jumped 201.97% since last year same period to $16.4Mn in the Q3 2023. On a quarterly growth basis, Mirati Therapeutics Inc has generated 19.8% jump in its revenue since last 3-months.
Mirati Therapeutics Inc’s net profit jumped 6.72% since last year same period to $-161.9Mn in the Q3 2023. On a quarterly growth basis, Mirati Therapeutics Inc has generated 8.48% jump in its net profits since last 3-months.
Mirati Therapeutics Inc’s net profit margin jumped 69.11% since last year same period to -987.22% in the Q3 2023. On a quarterly growth basis, Mirati Therapeutics Inc has generated 23.61% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Mirati Therapeutics Inc post its latest quarter earnings
EPS Estimate Current Quarter | -2.58 |
EPS Estimate Current Year | -2.58 |
Highlights
Mirati Therapeutics Inc’s earning per share (EPS) estimates for the current quarter stand at -2.58 - a 1.53% jump from last quarter’s estimates.
Mirati Therapeutics Inc’s earning per share (EPS) estimates for the current year stand at -2.58.
Key Ratios
Key ratios of the Mirati Therapeutics Inc post its Q3 2023 earnings
Earning Per Share (EPS) | -2.49 |
Highlights
Mirati Therapeutics Inc’s earning per share (EPS) jumped 19.42% since last year same period to -2.49 in the Q3 2023. This indicates that the Mirati Therapeutics Inc has generated 19.42% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2023-05-09 | -3.55 | -3.18 | 10.42% |
2023-08-08 | -3.17 | -3.04 | 4.1% |
2023-11-06 | -2.84 | -2.49 | 12.32% |
₹0 US Stocks a/c Opening Fee